Chapter 6 Posttranscriptional Gene Regulation in Kaposi's Sarcoma-Associated Herpesvirus

Advances in Applied Microbiology

Volumn 68, Issue , 2009, Pages 241-261

  Conrad, Nicholas K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN ORF 57; UNCLASSIFIED DRUG; VIRUS PROTEIN; PROTEIN;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CARCINOGENESIS; GENE CONTROL; GENE EXPRESSION; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; PATHOGENESIS; PRIMARY EFFUSION LYMPHOMA; REVIEW; RNA SPLICING; RNA STABILITY; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOGENICITY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

ANIMALS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; MICRORNAS; PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 65449181607     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2164(09)01206-4     Document Type: Review

References (123)

1. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
2. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., and Taganov K.D. MicroRNAs: New regulators of immune cell development and function. Nat. Immunol. 9 (2008) 839-845
3. Barreau C., Paillard L., and Osborne H.B. AU-rich elements and associated factors: Are there unifying principles?. Nucleic Acids Res. 33 (2005) 7138-7150
4. Bartel D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
5. Behm-Ansmant I., Rehwinkel J., Doerks T., Stark A., Bork P., and Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20 (2006) 1885-1898
6. Behm-Ansmant I., Rehwinkel J., and Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb. Symp. Quant. Biol. 71 (2006) 523-530
7. Bello L.J., Davison A.J., Glenn M.A., Whitehouse A., Rethmeier N., Schulz T.F., and Barklie Clements J. The human herpesvirus-8 ORF 57 gene and its properties. J. Gen. Virol. 80 Pt 12 (1999) 3207-3215
8. Boehm M., and Slack F.J. MicroRNA control of lifespan and metabolism. Cell Cycle 5 (2006) 837-840
9. Boyne J.R., Colgan K.J., and Whitehouse A. Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication. PLoS Pathog. 4 (2008) e1000194
10. Boyne J.R., and Whitehouse A. Gamma-2 Herpes virus post-transcriptional gene regulation. Clin. Microbiol. Infect. 12 (2006) 110-117
11. Brennan C.M., and Steitz J.A. HuR and mRNA stability. Cell Mol. Life Sci. 58 (2001) 266-277
12. Brown C.R., Nakamura M.S., Mosca J.D., Hayward G.S., Straus S.E., and Perera L.P. Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3′ ends of labile mRNA. J. Virol. 69 (1995) 7187-7195
13. Cai X., and Cullen B.R. Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs. J. Virol. 80 (2006) 2234-2242
14. Cai X., Lu S., Zhang Z., Gonzalez C.M., Damania B., and Cullen B.R. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. USA 102 (2005) 5570-5575
15. Cheng H., Dufu K., Lee C.S., Hsu J.L., Dias A., and Reed R. Human mRNA export machinery recruited to the 5′ end of mRNA. Cell 127 (2006) 1389-1400
16. Clurman B.E., and Hayward W.S. Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: Evidence for stage-specific events. Mol. Cell Biol. 9 (1989) 2657-2664
17. Cohen J.I., Bollard C.M., Khanna R., and Pittaluga S. Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leuk. Lymphoma 49 Suppl. 1 (2008) 27-34
18. Conrad N.K., Mili S., Marshall E.L., Shu M.D., and Steitz J.A. Identification of a rapid mammalian deadenylation-dependent decay pathway and its inhibition by a viral RNA element. Mol. Cell. 24 (2006) 943-953
19. Conrad N.K., Shu M.D., Uyhazi K.E., and Steitz J.A. Mutational analysis of a viral RNA element that counteracts rapid RNA decay by interaction with the polyadenylate tail. Proc. Natl. Acad. Sci. USA 104 (2007) 10412-10417
20. Conrad N.K., and Steitz J.A. A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J. 24 (2005) 1831-1841
21. Corcoran J.A., Hsu W.L., and Smiley J.R. Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 gene. J. Virol. 80 (2006) 9720-9729
22. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., and Croce C.M. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103 (2006) 7024-7029
23. Croce C.M. MicroRNAs and lymphomas. Ann. Oncol. 19 Suppl. 4 (2008) iv39-iv40
24. Custodio N., Carvalho C., Condado I., Antoniou M., Blencowe B.J., and Carmo-Fonseca M. In vivo recruitment of exon junction complex proteins to transcription sites in mammalian cell nuclei. RNA 10 (2004) 622-633
25. Dean J.L., Sully G., Clark A.R., and Saklatvala J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 16 (2004) 1113-1121
26. Deng H., Liang Y., and Sun R. Regulation of KSHV lytic gene expression. Curr. Top. Microbiol. Immunol. 312 (2007) 157-183
27. Deng S., Calin G.A., Croce C.M., Coukos G., and Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7 (2008) 2643-2646
28. Du M.Q., Bacon C.M., and Isaacson P.G. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J. Clin. Pathol. 60 (2007) 1350-1357
29. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., and Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 102 (2005) 3627-3632
30. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
31. Fontoura B.M., Faria P.A., and Nussenzveig D.R. Viral interactions with the nuclear transport machinery: Discovering and disrupting pathways. IUBMB Life 57 (2005) 65-72
32. Friedman R.C., Farh K.K., Burge C.B., and Bartel D. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008)
33. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 1 (2006) 273-296
34. Gilbert W., and Guthrie C. The Glc7p nuclear phosphatase promotes mRNA export by facilitating association of Mex67p with mRNA. Mol. Cell 13 (2004) 201-212
35. Giraldez A.J., Mishima Y., Rihel J., Grocock R.J., Van Dongen S., Inoue K., Enright A.J., and Schier A.F. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312 (2006) 75-79
36. Glaunsinger B., Chavez L., and Ganem D. The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable. J. Virol. 79 (2005) 7396-7401
37. Glaunsinger B., and Ganem D. Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J. Exp. Med. 200 (2004) 391-398
38. Glaunsinger B., and Ganem D. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 13 (2004) 713-723
39. Glaunsinger B.A., and Ganem D.E. Messenger RNA turnover and its regulation in herpesviral infection. Adv. Virus Res. 66 (2006) 337-394
40. Gottwein E., and Cullen B.R. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3 (2008) 375-387
41. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., Braich R., Manoharan M., Soutschek J., Ohler U., and Cullen B.R. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450 (2007) 1096-1099
42. Grundhoff A., Sullivan C.S., and Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12 (2006) 733-750
43. Gupta A.K., Ruvolo V., Patterson C., and Swaminathan S. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. J. Virol. 74 (2000) 1038-1044
44. Han Z., and Swaminathan S. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J. Virol. 80 (2006) 5251-5260
45. Hayward S.D., Liu J., and Fujimuro M. Notch and Wnt signaling: Mimicry and manipulation by gamma herpesviruses. Sci. STKE 2006 (2006) re4
46. He L., and Hannon G.J. MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5 (2004) 522-531
47. Huang Y., Gattoni R., Stevenin J., and Steitz J.A. SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Mol. Cell 11 (2003) 837-843
48. Jenner R.G., Alba M.M., Boshoff C., and Kellam P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75 (2001) 891-902
49. Jiang J., Lee E.J., and Schmittgen T.D. Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines. Genes Chromosomes Cancer 45 (2006) 103-106
50. Khabar K.S. The AU-rich transcriptome: More than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res. 25 (2005) 1-10
51. Kirshner J.R., Lukac D.M., Chang J., and Ganem D. Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J. Virol. 74 (2000) 3586-3597
52. Kluiver J., Poppema S., de Jong D., Blokzijl T., Harms G., Jacobs S., Kroesen B.J., and van den Berg A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207 (2005) 243-249
53. Lamond A.I., and Spector D.L. Nuclear speckles: A model for nuclear organelles. Nat. Rev. Mol. Cell Biol. 4 (2003) 605-612
54. Laurent C., Meggetto F., and Brousset P. Human herpesvirus 8 infections in patients with immunodeficiencies. Hum. Pathol. 39 (2008) 983-993
55. Lee Y., Han J., Yeom K.H., Jin H., and Kim V.N. Drosha in primary microRNA processing. Cold Spring Harb. Symp. Quant. Biol. 71 (2006) 51-57
56. Le Hir H., Nott A., and Moore M.J. How introns influence and enhance eukaryotic gene expression. Trends Biochem. Sci. 28 (2003) 215-220
57. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., and Burge C.B. Prediction of mammalian microRNA targets. Cell 115 (2003) 787-798
58. Licatalosi D.D., Mele A., Fak J.J., Ule J., Kayikci M., Chi S.W., Clark T.A., Schweitzer A.C., Blume J.E., Wang X., Darnell J.C., and Darnell R.B. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456 (2008) 464-469
59. Majerciak V., Pripuzova N., McCoy J.P., Gao S.J., and Zheng Z.M. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus. J. Virol. 81 (2007) 1062-1071
60. Majerciak V., Yamanegi K., Allemand E., Kruhlak M., Krainer A.R., and Zheng Z.M. Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J. Virol. 82 (2008) 2792-2801
61. Majerciak V., Yamanegi K., Nie S.H., and Zheng Z.M. Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J. Biol. Chem. 281 (2006) 28365-28378
62. Majerciak V., Yamanegi K., and Zheng Z.M. Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J. Virol. 80 (2006) 11968-11981
63. Malik P., Blackbourn D.J., Cheng M.F., Hayward G.S., and Clements J.B. Functional co-operation between the Kaposi's sarcoma-associated herpesvirus ORF57 and ORF50 regulatory proteins. J. Gen. Virol. 85 (2004) 2155-2166
64. Malik P., Blackbourn D.J., and Clements J.B. The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J. Biol. Chem. 279 (2004) 33001-33011
65. Malik P., and Schirmer E.C. The Kaposi's sarcoma-associated herpesvirus ORF57 protein: A pleurotropic regulator of gene expression. Biochem. Soc. Trans. 34 (2006) 705-710
66. Maniatis T., and Reed R. An extensive network of coupling among gene expression machines. Nature 416 (2002) 499-506
67. Marshall V., Parks T., Bagni R., Wang C.D., Samols M.A., Hu J., Wyvil K.M., Aleman K., Little R.F., Yarchoan R., Renne R., and Whitby D. Conservation of virally encoded microRNAs in Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J. Infect. Dis. 195 (2007) 645-659
68. Masuda S., Das R., Cheng H., Hurt E., Dorman N., and Reed R. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 19 (2005) 1512-1517
69. Matis J., and Kudelova M. Early shutoff of host protein synthesis in cells infected with herpes simplex viruses. Acta Virol. 45 (2001) 269-277
70. McCormick C., and Ganem D. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307 (2005) 739-741
71. Metzler M., Wilda M., Busch K., Viehmann S., and Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39 (2004) 167-169
72. Moore P.S., and Chang Y. Antiviral activity of tumor-suppressor pathways: Clues from molecular piracy by KSHV. Trends Genet. 14 (1998) 144-150
73. Muhlrad D., and Parker R. The yeast EDC1 mRNA undergoes deadenylation-independent decapping stimulated by Not2p, Not4p, and Not5p. EMBO J. 24 (2005) 1033-1045
74. Murphy E., Vanicek J., Robins H., Shenk T., and Levine A.J. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: Implications for latency. Proc. Natl. Acad. Sci. USA 105 (2008) 5453-5458
75. Nekorchuk M., Han Z., Hsieh T.T., and Swaminathan S. Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export. J. Virol. 81 (2007) 9990-9998
76. Nicewonger J., Suck G., Bloch D., and Swaminathan S. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression. J. Virol. 78 (2004) 9412-9422
77. Nicholas J. Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia. Front Biosci. 12 (2007) 265-281
78. Palmeri D., Spadavecchia S., Carroll K.D., and Lukac D.M. Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein. J. Virol. 81 (2007) 13299-13314
79. Pan Q., Shai O., Lee L.J., Frey B.J., and Blencowe B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40 (2008) 1413-1415
80. Pearce M., Matsumura S., and Wilson A.C. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J. Virol. 79 (2005) 14457-14464
81. Pellet P.E., and Roizman B. The Family Herpesviridae: A Brief Introduction. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology". 5th Edition. (2007), Lippincott Williams and Wilkins
82. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., et al. Identification of microRNAs of the herpesvirus family. Nat. Methods 2 (2005) 269-276
83. Rahadiani N., Takakuwa T., Tresnasari K., Morii E., and Aozasa K. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem. Biophys. Res. Commun. (2008)
84. Reed R., and Cheng H. TREX, SR proteins and export of mRNA. Curr. Opin. Cell Biol. 17 (2005) 269-273
85. Rowe M., Glaunsinger B., van Leeuwen D., Zuo J., Sweetman D., Ganem D., Middeldorp J., Wiertz E.J., and Ressing M.E. Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc. Natl. Acad. Sci. USA 104 (2007) 3366-3371
86. Sadler R., Wu L., Forghani B., Renne R., Zhong W., Herndier B., and Ganem D. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73 (1999) 5722-5730
87. Samols M.A., Hu J., Skalsky R.L., and Renne R. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79 (2005) 9301-9305
88. Samols M.A., Skalsky R.L., Maldonado A.M., Riva A., Lopez M.C., Baker H.V., and Renne R. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 3 (2007) e65
89. Sandri-Goldin R.M. The many roles of the regulatory protein ICP27 during herpes simplex virus infection. Front Biosci. 13 (2008) 5241-5256
90. Skalsky R.L., Samols M.A., Plaisance K.B., Boss I.W., Riva A., Lopez M.C., Baker H.V., and Renne R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81 (2007) 12836-12845
91. Song M.J., Brown H.J., Wu T.T., and Sun R. Transcription activation of polyadenylated nuclear RNA by Rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 (2001) 3129-3140
92. Staudt M.R., and Dittmer D.P. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr. Top. Microbiol. Immunol. 312 (2007) 71-100
93. Strasser K., Masuda S., Mason P., Pfannstiel J., Oppizzi M., Rodriguez-Navarro S., Rondon A.G., Aguilera A., Struhl K., Reed R., and Hurt E. TREX is a conserved complex coupling transcription with messenger RNA export. Nature 417 (2002) 304-308
94. Sullivan R.J., Pantanowitz L., Casper C., Stebbing J., and Dezube B.J. HIV/AIDS: Epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin. Infect. Dis. 47 (2008) 1209-1215
95. Sun R., Lin S.F., Gradoville L., and Miller G. Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 93 (1996) 11883-11888
96. Sun R., Lin S.F., Staskus K., Gradoville L., Grogan E., Haase A., and Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73 (1999) 2232-2242
97. Swaminathan S. Post-transcriptional gene regulation by gamma herpesviruses. J. Cell Biochem. 95 (2005) 698-711
98. Taddeo B., Esclatine A., and Roizman B. Post-transcriptional processing of cellular RNAs in herpes simplex virus-infected cells. Biochem. Soc. Trans. 32 (2004) 697-701
99. Tam W., Ben-Yehuda D., and Hayward W.S. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell Biol. 17 (1997) 1490-1502
100. Tam W., Hughes S.H., Hayward W.S., and Besmer P. Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J. Virol. 76 (2002) 4275-4286
101. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., Schmidt-Supprian M., Rajewsky N., et al. Regulation of the germinal center response by microRNA-155. Science 316 (2007) 604-608
102. Thorley-Lawson D.A., and Allday M.J. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat. Rev. Microbiol. 6 (2008) 913-924
103. Tili E., Michaille J.J., Costinean S., and Croce C.M. MicroRNAs, the immune system and rheumatic disease. Nat. Clin. Pract. Rheumatol. 4 (2008) 534-541
104. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., and Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454 (2008) 780-783
105. Valencia P., Dias A.P., and Reed R. Splicing promotes rapid and efficient mRNA export in mammalian cells. Proc. Natl. Acad. Sci. USA 105 (2008) 3386-3391
106. Verma D., and Swaminathan S. Epstein-Barr virus SM protein functions as an alternative splicing factor. J. Virol. (2008)
107. Verma S.C., Lan K., and Robertson E. Structure and function of latency-associated nuclear antigen. Curr. Top. Microbiol. Immunol. 312 (2007) 101-136
108. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., and Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 456 (2008) 470-476
109. Wang H.W., and Boshoff C. Linking Kaposi virus to cancer-associated cytokines. Trends Mol. Med. 11 (2005) 309-312
110. Weis K. Nucleocytoplasmic transport: Cargo trafficking across the border. Curr. Opin. Cell Biol. 14 (2002) 328-335
111. West J.T., and Wood C. The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Oncogene 22 (2003) 5150-5163
112. Wilkinson D.E., and Weller S.K. The role of DNA recombination in herpes simplex virus DNA replication. IUBMB Life 55 (2003) 451-458
113. Wilusz J.E., Freier S.M., and Spector D.L. 3′ end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 135 (2008) 919-932
114. Wu L., Fan J., and Belasco J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. USA 103 (2006) 4034-4039
115. Yekta S., Tabin C.J., and Bartel D.P. MicroRNAs in the Hox network: An apparent link to posterior prevalence. Nat. Rev. Genet. 9 (2008) 789-796
116. Yin Q., McBride J., Fewell C., Lacey M., Wang X., Lin Z., Cameron J., and Flemington E.K. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82 (2008) 5295-5306
117. Zhao Y., Yao Y., Xu H., Lambeth L., Smith L.P., Kgosana L., Wang X., and Nair V. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J. Virol. 83 (2009) 489-492
118. Zheng Z.M. Split genes and their expression in Kaposi's sarcoma-associated herpesvirus. Rev. Med. Virol. 13 (2003) 173-184
119. Zhong W., and Ganem D. Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J. Virol. 71 (1997) 1207-1212
120. Zhong W., Wang H., Herndier B., and Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. USA 93 (1996) 6641-6646
121. Zhou F.C., Zhang Y.J., Deng J.H., Wang X.P., Pan H.Y., Hettler E., and Gao S.J. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: Application for genetic analysis. J. Virol. 76 (2002) 6185-6196
122. Ziegelbauer J.M., Sullivan C.S., and Ganem D. Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat. Genet. 41 (2009) 130-134
123. Zuo J., Thomas W., van Leeuwen D., Middeldorp J.M., Wiertz E.J., Ressing M.E., and Rowe M. The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function. J. Virol. 82 (2008) 2385-2393